To determine the optimal dosing regimen, we treated the mice with XIP up to three times per day, simulating the multiple daily insulin injections required for T1D patients, and repeated fasting–feeding cycles were scheduled to mimic human eating patterns (Figure S18e, Supporting Information). Here, INS is linked to type 1 diabetes mellitus.